应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
FGEN FibroGen, Inc
休市中 07-11 16:00:00 EDT
7.15
-0.20
-2.72%
盘后
7.15
+0.00
0.00%
19:00 EDT
最高
7.72
最低
7.11
成交量
5.99万
今开
7.45
昨收
7.35
日振幅
8.30%
总市值
2,890万
流通市值
2,603万
总股本
404.18万
成交额
44.19万
换手率
1.64%
流通股本
364.11万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
珐博进7月10日成交额为162.77万美元
市场透视 · 07-11 02:10
珐博进7月10日成交额为162.77万美元
珐博进盘中异动 早盘股价大涨5.01%
市场透视 · 07-10
珐博进盘中异动 早盘股价大涨5.01%
珐博进7月9日成交额为54.46万美元
市场透视 · 07-10
珐博进7月9日成交额为54.46万美元
珐博进7月8日成交额为16.23万美元
市场透视 · 07-09
珐博进7月8日成交额为16.23万美元
珐博进盘中异动 下午盘股价大涨5.21%报5.65美元
市场透视 · 07-08
珐博进盘中异动 下午盘股价大涨5.21%报5.65美元
珐博进7月7日成交额为20.48万美元
市场透视 · 07-08
珐博进7月7日成交额为20.48万美元
珐博进7月3日成交额为18.56万美元
市场透视 · 07-04
珐博进7月3日成交额为18.56万美元
珐博进盘中异动 早盘股价大涨6.29%报5.58美元
市场透视 · 07-03
珐博进盘中异动 早盘股价大涨6.29%报5.58美元
珐博进7月2日成交额为40.53万美元
市场透视 · 07-03
珐博进7月2日成交额为40.53万美元
珐博进7月1日成交额为11.06万美元
市场透视 · 07-02
珐博进7月1日成交额为11.06万美元
珐博进盘中异动 股价大跌5.36%
市场透视 · 06-30
珐博进盘中异动 股价大跌5.36%
珐博进6月27日成交额为31.39万美元
市场透视 · 06-28
珐博进6月27日成交额为31.39万美元
珐博进6月25日成交额为24.61万美元
市场透视 · 06-26
珐博进6月25日成交额为24.61万美元
珐博进6月24日成交额为14.73万美元
市场透视 · 06-25
珐博进6月24日成交额为14.73万美元
珐博进6月23日成交额为27.05万美元
市场透视 · 06-24
珐博进6月23日成交额为27.05万美元
珐博进盘中异动 大幅拉升9.30%报5.64美元
市场透视 · 06-20
珐博进盘中异动 大幅拉升9.30%报5.64美元
珐博进6月17日成交额为99.11万美元
市场透视 · 06-18
珐博进6月17日成交额为99.11万美元
珐博进6月16日成交额为26.88万美元
市场透视 · 06-17
珐博进6月16日成交额为26.88万美元
珐博进盘中异动 早盘股价大涨5.23%
市场透视 · 06-16
珐博进盘中异动 早盘股价大涨5.23%
珐博进盘中异动 大幅下挫7.68%报0.285美元
市场透视 · 06-13
珐博进盘中异动 大幅下挫7.68%报0.285美元
加载更多
公司概况
公司名称:
FibroGen, Inc
所属市场:
NASDAQ
上市日期:
--
主营业务:
Fibrogen, Inc.于1993年在美国特拉华州注册成立。该公司是一家生物制药公司,专注于癌症生物学和贫血前沿领域的新疗法开发。该公司正在开发FG-3246,这是一种潜在的靶向CD46的first-in-class抗体药物偶联物,用于治疗转移性去势抵抗性前列腺癌和潜在的其他癌症。该计划还包括FG-3180的开发,这是一种相关的CD46靶向正电子发射断层扫描生物标志物和显像剂。
发行价格:
--
{"stockData":{"symbol":"FGEN","market":"US","secType":"STK","nameCN":"FibroGen, Inc","latestPrice":7.15,"timestamp":1752264000000,"preClose":7.35,"halted":0,"volume":59889,"hourTrading":{"tag":"盘后","latestPrice":7.15,"preClose":7.15,"latestTime":"19:00 EDT","volume":171,"amount":1229.36,"timestamp":1752274835116},"delay":0,"floatShares":3641100,"shares":4041758,"eps":-2.488387,"marketStatus":"休市中","change":-0.2,"latestTime":"07-11 16:00:00 EDT","open":7.45,"high":7.7199,"low":7.11,"amount":441902.0360205,"amplitude":0.08298,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.488387,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1415941200000,"exchange":"NASDAQ","adjPreClose":7.35,"preHourTrading":{"tag":"盘前","latestPrice":7.37,"preClose":7.35,"latestTime":"09:23 EDT","volume":1441,"amount":10685.5914,"timestamp":1752240233033},"postHourTrading":{"tag":"盘后","latestPrice":7.15,"preClose":7.15,"latestTime":"19:00 EDT","volume":171,"amount":1229.36,"timestamp":1752274835116},"volumeRatio":0.7154085982546536,"impliedVol":1.651,"impliedVolPercentile":0.7991},"requestUrl":"/m/hq/s/FGEN","defaultTab":"news","newsList":[{"id":"2550606427","title":"珐博进7月10日成交额为162.77万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550606427","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550606427?lang=zh_cn&edition=full","pubTime":"2025-07-11 10:10","pubTimestamp":1752199816,"startTime":"0","endTime":"0","summary":"美东时间2025年7月10日,珐博进成交额为162.77万美元,成交额较昨日增加198.88%,当日成交量为22.80万股。珐博进于2025年7月10日涨18.74%,报7.35美元,该股过去5个交易日涨40.0%,年初至今跌44.53%,过去60日涨6.14%。该公司的绝大部分收入来自欧洲,其次是日本。迄今为止,珐博进几乎所有的收入都来自其合作协议。珐博进寻求具有研究、开发和营销能力以及其他资源的合作伙伴,以增强公司推进候选产品的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711101024a443a7f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711101024a443a7f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","FGEN"],"gpt_icon":0},{"id":"2550625762","title":"珐博进盘中异动 早盘股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550625762","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550625762?lang=zh_cn&edition=full","pubTime":"2025-07-10 21:47","pubTimestamp":1752155252,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日21时47分,珐博进股票出现波动,股价快速拉升5.01%。截至发稿,该股报6.50美元/股,成交量6915股,换手率0.17%,振幅4.28%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。珐博进股票所在的生物技术行业中,整体跌幅为0.04%。该公司的绝大部分收入来自欧洲,其次是日本。迄今为止,珐博进几乎所有的收入都来自其合作协议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710214732953d8673&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710214732953d8673&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FGEN","BK4007","CGTX","BK4139","BK4505"],"gpt_icon":0},{"id":"2550695130","title":"珐博进7月9日成交额为54.46万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550695130","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550695130?lang=zh_cn&edition=full","pubTime":"2025-07-10 10:07","pubTimestamp":1752113239,"startTime":"0","endTime":"0","summary":"美东时间2025年7月9日,珐博进成交额为54.46万美元,成交额较昨日增加235.53%,当日成交量为9.11万股。珐博进于2025年7月9日涨10.14%,报6.19美元,该股过去5个交易日涨17.46%,年初至今跌53.28%,过去60日跌4.77%。该公司的绝大部分收入来自欧洲,其次是日本。迄今为止,珐博进几乎所有的收入都来自其合作协议。珐博进寻求具有研究、开发和营销能力以及其他资源的合作伙伴,以增强公司推进候选产品的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710100725a6a080b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710100725a6a080b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","FGEN"],"gpt_icon":0},{"id":"2550503891","title":"珐博进7月8日成交额为16.23万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550503891","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550503891?lang=zh_cn&edition=full","pubTime":"2025-07-09 10:05","pubTimestamp":1752026731,"startTime":"0","endTime":"0","summary":"美东时间2025年7月8日,珐博进成交额为16.23万美元,成交额较昨日减少20.73%,当日成交量为2.91万股。珐博进于2025年7月8日涨4.66%,报5.62美元,该股过去5个交易日涨6.04%,年初至今跌57.58%,过去60日跌14.52%。该公司的绝大部分收入来自欧洲,其次是日本。迄今为止,珐博进几乎所有的收入都来自其合作协议。珐博进寻求具有研究、开发和营销能力以及其他资源的合作伙伴,以增强公司推进候选产品的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709100541a69e3ba5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709100541a69e3ba5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FGEN","BK4505"],"gpt_icon":0},{"id":"2550520835","title":"珐博进盘中异动 下午盘股价大涨5.21%报5.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550520835","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550520835?lang=zh_cn&edition=full","pubTime":"2025-07-09 02:41","pubTimestamp":1752000075,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日02时41分,珐博进股票出现异动,股价大幅拉升5.21%。截至发稿,该股报5.65美元/股,成交量1.8091万股,换手率0.45%,振幅4.24%。最近的财报数据显示,该股实现营业收入2.74百万美元,净利润-16.77百万美元,每股收益1.15美元,毛利2.16百万美元,市盈率-2.24倍。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。珐博进股票所在的生物技术行业中,整体涨幅为1.07%。迄今为止,珐博进几乎所有的收入都来自其合作协议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709024116979ea923&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709024116979ea923&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","FGEN","BK4139"],"gpt_icon":0},{"id":"2549928560","title":"珐博进7月7日成交额为20.48万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549928560","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549928560?lang=zh_cn&edition=full","pubTime":"2025-07-08 10:05","pubTimestamp":1751940300,"startTime":"0","endTime":"0","summary":"美东时间2025年7月7日,珐博进成交额为20.48万美元,成交额较昨日增加10.29%,当日成交量为3.73万股。珐博进于2025年7月7日跌4.28%,报5.37美元,该股过去5个交易日涨2.87%,年初至今跌59.47%,过去60日跌14.76%。该公司的绝大部分收入来自欧洲,其次是日本。迄今为止,珐博进几乎所有的收入都来自其合作协议。珐博进寻求具有研究、开发和营销能力以及其他资源的合作伙伴,以增强公司推进候选产品的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708100503a43ce732&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708100503a43ce732&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","FGEN"],"gpt_icon":0},{"id":"2548378283","title":"珐博进7月3日成交额为18.56万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548378283","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548378283?lang=zh_cn&edition=full","pubTime":"2025-07-04 10:06","pubTimestamp":1751594783,"startTime":"0","endTime":"0","summary":"美东时间2025年7月3日,珐博进成交额为18.56万美元,成交额较昨日减少54.20%,当日成交量为3.31万股。珐博进于2025年7月3日涨6.86%,报5.61美元,该股过去5个交易日涨5.85%,年初至今跌57.66%,过去60日跌17.8%。该公司的绝大部分收入来自欧洲,其次是日本。迄今为止,珐博进几乎所有的收入都来自其合作协议。珐博进寻求具有研究、开发和营销能力以及其他资源的合作伙伴,以增强公司推进候选产品的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704100633a72dc007&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704100633a72dc007&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FGEN","BK4505","BK4139"],"gpt_icon":0},{"id":"2548807778","title":"珐博进盘中异动 早盘股价大涨6.29%报5.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548807778","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548807778?lang=zh_cn&edition=full","pubTime":"2025-07-03 21:31","pubTimestamp":1751549466,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日21时31分,珐博进股票出现波动,股价急速拉升6.29%。截至发稿,该股报5.58美元/股,成交量3469股,换手率0.09%,振幅0.00%。机构评级方面,目前暂无机构对该股做出“买入、持有、卖出”建议。珐博进股票所在的生物技术行业中,整体涨幅为0.10%。该公司的绝大部分收入来自欧洲,其次是日本。迄今为止,珐博进几乎所有的收入都来自其合作协议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703213107a72cdaad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703213107a72cdaad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FGEN","BK4505"],"gpt_icon":0},{"id":"2548682836","title":"珐博进7月2日成交额为40.53万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548682836","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548682836?lang=zh_cn&edition=full","pubTime":"2025-07-03 10:05","pubTimestamp":1751508305,"startTime":"0","endTime":"0","summary":"美东时间2025年7月2日,珐博进成交额为40.53万美元,成交额较昨日增加266.56%,当日成交量为7.50万股。珐博进于2025年7月2日跌0.38%,报5.25美元,该股过去5个交易日跌8.06%,年初至今跌60.38%,过去60日跌25.0%。该公司的绝大部分收入来自欧洲,其次是日本。迄今为止,珐博进几乎所有的收入都来自其合作协议。珐博进寻求具有研究、开发和营销能力以及其他资源的合作伙伴,以增强公司推进候选产品的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703100516a4cc3b26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703100516a4cc3b26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FGEN","BK4139","BK4505"],"gpt_icon":0},{"id":"2548830614","title":"珐博进7月1日成交额为11.06万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548830614","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548830614?lang=zh_cn&edition=full","pubTime":"2025-07-02 10:03","pubTimestamp":1751421837,"startTime":"0","endTime":"0","summary":"美东时间2025年7月1日,珐博进成交额为11.06万美元,成交额较昨日减少72.33%,当日成交量为2.10万股。珐博进于2025年7月1日跌0.57%,报5.27美元,该股过去5个交易日跌3.13%,年初至今跌60.23%,过去60日跌28.3%。该公司的绝大部分收入来自欧洲,其次是日本。迄今为止,珐博进几乎所有的收入都来自其合作协议。珐博进寻求具有研究、开发和营销能力以及其他资源的合作伙伴,以增强公司推进候选产品的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702100408a4ca080e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702100408a4ca080e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FGEN","BK4505","BK4139"],"gpt_icon":0},{"id":"2547018785","title":"珐博进盘中异动 股价大跌5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547018785","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547018785?lang=zh_cn&edition=full","pubTime":"2025-06-30 22:37","pubTimestamp":1751294266,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日22时37分,珐博进股票出现波动,股价急速下跌5.36%。截至发稿,该股报4.94美元/股,成交量1.7395万股,换手率0.43%,振幅7.47%。机构评级方面,在所有2家参与评级的机构中,50%的券商给予买入建议,50%的券商给予持有建议,无券商给予卖出建议。珐博进股票所在的生物技术行业中,整体涨幅为0.80%。迄今为止,珐博进几乎所有的收入都来自其合作协议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630223746a7266198&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630223746a7266198&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FGEN","BK4505"],"gpt_icon":0},{"id":"2546731827","title":"珐博进6月27日成交额为31.39万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546731827","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546731827?lang=zh_cn&edition=full","pubTime":"2025-06-28 10:04","pubTimestamp":1751076287,"startTime":"0","endTime":"0","summary":"美东时间2025年6月27日,珐博进成交额为31.39万美元,成交额较昨日减少7.99%,当日成交量为5.97万股。珐博进于2025年6月27日跌1.51%,报5.22美元,该股过去5个交易日跌9.22%,年初至今跌60.6%,过去60日跌30.4%。该公司的绝大部分收入来自欧洲,其次是日本。迄今为止,珐博进几乎所有的收入都来自其合作协议。珐博进寻求具有研究、开发和营销能力以及其他资源的合作伙伴,以增强公司推进候选产品的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628100453a721e4f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628100453a721e4f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FGEN","BK4505"],"gpt_icon":0},{"id":"2546765532","title":"珐博进6月25日成交额为24.61万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546765532","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546765532?lang=zh_cn&edition=full","pubTime":"2025-06-26 10:06","pubTimestamp":1750903567,"startTime":"0","endTime":"0","summary":"美东时间2025年6月25日,珐博进成交额为24.61万美元,成交额较昨日增加67.08%,当日成交量为4.41万股。珐博进于2025年6月25日涨4.96%,报5.71美元,该股过去5个交易日跌2.89%,年初至今跌56.91%,过去60日跌27.26%。迄今为止,珐博进几乎所有的收入都来自其合作协议。珐博进寻求具有研究、开发和营销能力以及其他资源的合作伙伴,以增强公司推进候选产品的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626100612a71dfdb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626100612a71dfdb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","FGEN"],"gpt_icon":0},{"id":"2546526351","title":"珐博进6月24日成交额为14.73万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546526351","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546526351?lang=zh_cn&edition=full","pubTime":"2025-06-25 10:03","pubTimestamp":1750817015,"startTime":"0","endTime":"0","summary":"美东时间2025年6月24日,珐博进成交额为14.73万美元,成交额较昨日减少45.53%,当日成交量为2.74万股。珐博进于2025年6月24日涨0.74%,报5.44美元,该股过去5个交易日跌18.2%,年初至今跌58.94%,过去60日跌33.66%。该公司的绝大部分收入来自欧洲,其次是日本。迄今为止,珐博进几乎所有的收入都来自其合作协议。珐博进寻求具有研究、开发和营销能力以及其他资源的合作伙伴,以增强公司推进候选产品的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625100337a71c2350&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625100337a71c2350&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","FGEN"],"gpt_icon":0},{"id":"2545642701","title":"珐博进6月23日成交额为27.05万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545642701","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545642701?lang=zh_cn&edition=full","pubTime":"2025-06-24 10:03","pubTimestamp":1750730595,"startTime":"0","endTime":"0","summary":"美东时间2025年6月23日,珐博进成交额为27.05万美元,成交额较昨日减少42.14%,当日成交量为4.93万股。珐博进于2025年6月23日跌6.09%,报5.4美元,该股过去5个交易日跌18.18%,年初至今跌59.25%,过去60日跌36.47%。该公司的绝大部分收入来自欧洲,其次是日本。迄今为止,珐博进几乎所有的收入都来自其合作协议。珐博进寻求具有研究、开发和营销能力以及其他资源的合作伙伴,以增强公司推进候选产品的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624100316a4ba8c5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624100316a4ba8c5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FGEN","BK4139","BK4505"],"gpt_icon":0},{"id":"2544527173","title":"珐博进盘中异动 大幅拉升9.30%报5.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544527173","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544527173?lang=zh_cn&edition=full","pubTime":"2025-06-20 21:35","pubTimestamp":1750426513,"startTime":"0","endTime":"0","summary":"北京时间2025年06月20日21时35分,珐博进股票出现异动,股价急速拉升9.30%。截至发稿,该股报5.64美元/股,成交量7244股,换手率0.18%,振幅1.74%。机构评级方面,在所有2家参与评级的机构中,50%的券商给予买入建议,50%的券商给予持有建议,无券商给予卖出建议。珐博进股票所在的生物技术行业中,整体涨幅为0.33%。该公司的绝大部分收入来自欧洲,其次是日本。迄今为止,珐博进几乎所有的收入都来自其合作协议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620213513978809bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250620213513978809bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","FGEN"],"gpt_icon":0},{"id":"2544894826","title":"珐博进6月17日成交额为99.11万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544894826","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544894826?lang=zh_cn&edition=full","pubTime":"2025-06-18 10:06","pubTimestamp":1750212365,"startTime":"0","endTime":"0","summary":"美东时间2025年6月17日,珐博进成交额为99.11万美元,成交额较昨日增加268.75%,当日成交量为15.38万股。珐博进于2025年6月17日跌11.61%,报5.88美元,该股过去5个交易日跌23.88%,年初至今跌55.62%,过去60日跌25.33%。该公司的绝大部分收入来自欧洲,其次是日本。迄今为止,珐博进几乎所有的收入都来自其合作协议。珐博进寻求具有研究、开发和营销能力以及其他资源的合作伙伴,以增强公司推进候选产品的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618100608a4af87c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250618100608a4af87c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","FGEN","BK4139"],"gpt_icon":0},{"id":"2544336789","title":"珐博进6月16日成交额为26.88万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544336789","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544336789?lang=zh_cn&edition=full","pubTime":"2025-06-17 10:05","pubTimestamp":1750125917,"startTime":"0","endTime":"0","summary":"美东时间2025年6月16日,珐博进成交额为26.88万美元,成交额较昨日减少73.81%,当日成交量为100.54万股。珐博进于2025年6月16日涨0.83%,报0.266美元,该股过去5个交易日跌16.84%,年初至今跌49.79%,过去60日跌21.04%。该公司的绝大部分收入来自欧洲,其次是日本。迄今为止,珐博进几乎所有的收入都来自其合作协议。珐博进寻求具有研究、开发和营销能力以及其他资源的合作伙伴,以增强公司推进候选产品的能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617100525a4ad3ffb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617100525a4ad3ffb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","FGEN","BK4505"],"gpt_icon":0},{"id":"2543608240","title":"珐博进盘中异动 早盘股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543608240","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543608240?lang=zh_cn&edition=full","pubTime":"2025-06-16 21:39","pubTimestamp":1750081191,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日21时39分,珐博进股票出现波动,股价大幅拉升5.23%。截至发稿,该股报0.278美元/股,成交量5.4173万股,换手率0.05%,振幅4.55%。机构评级方面,在所有2家参与评级的机构中,50%的券商给予买入建议,50%的券商给予持有建议,无券商给予卖出建议。珐博进股票所在的生物技术行业中,整体跌幅为0.18%。该公司的绝大部分收入来自欧洲,其次是日本。迄今为止,珐博进几乎所有的收入都来自其合作协议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616213951a4ac36a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616213951a4ac36a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FGEN","BK4505","BK4139"],"gpt_icon":0},{"id":"2543680190","title":"珐博进盘中异动 大幅下挫7.68%报0.285美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543680190","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543680190?lang=zh_cn&edition=full","pubTime":"2025-06-13 21:33","pubTimestamp":1749821626,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日21时33分,珐博进股票出现波动,股价大幅下跌7.68%。截至发稿,该股报0.285美元/股,成交量23.5211万股,换手率0.23%,振幅2.56%。机构评级方面,在所有2家参与评级的机构中,50%的券商给予买入建议,50%的券商给予持有建议,无券商给予卖出建议。珐博进股票所在的生物技术行业中,整体跌幅为0.60%。该公司的绝大部分收入来自欧洲,其次是日本。迄今为止,珐博进几乎所有的收入都来自其合作协议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613213346a707a1f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613213346a707a1f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FGEN","BK4139","BK4505"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fibrogen.com","stockEarnings":[{"period":"1week","weight":0.2745},{"period":"1month","weight":-0.0744},{"period":"3month","weight":0.0317},{"period":"6month","weight":-0.5357},{"period":"1year","weight":-0.708},{"period":"ytd","weight":-0.4599}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fibrogen, Inc.于1993年在美国特拉华州注册成立。该公司是一家生物制药公司,专注于癌症生物学和贫血前沿领域的新疗法开发。该公司正在开发FG-3246,这是一种潜在的靶向CD46的first-in-class抗体药物偶联物,用于治疗转移性去势抵抗性前列腺癌和潜在的其他癌症。该计划还包括FG-3180的开发,这是一种相关的CD46靶向正电子发射断层扫描生物标志物和显像剂。","yearOnYearQuotes":[{"month":1,"riseRate":0.727273,"avgChangeRate":0.196681},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.032668},{"month":3,"riseRate":0.181818,"avgChangeRate":-0.060681},{"month":4,"riseRate":0.272727,"avgChangeRate":-0.133734},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.039352},{"month":6,"riseRate":0.636364,"avgChangeRate":-0.001658},{"month":7,"riseRate":0.545455,"avgChangeRate":-0.030754},{"month":8,"riseRate":0.3,"avgChangeRate":-0.058172},{"month":9,"riseRate":0.4,"avgChangeRate":-0.013866},{"month":10,"riseRate":0.5,"avgChangeRate":-0.068025},{"month":11,"riseRate":0.8,"avgChangeRate":0.107257},{"month":12,"riseRate":0.7,"avgChangeRate":0.105918}],"exchange":"NASDAQ","name":"FibroGen, Inc","nameEN":"FibroGen"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"FibroGen, Inc(FGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供FibroGen, Inc(FGEN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"FibroGen, Inc,FGEN,FibroGen, Inc股票,FibroGen, Inc股票老虎,FibroGen, Inc股票老虎国际,FibroGen, Inc行情,FibroGen, Inc股票行情,FibroGen, Inc股价,FibroGen, Inc股市,FibroGen, Inc股票价格,FibroGen, Inc股票交易,FibroGen, Inc股票购买,FibroGen, Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"FibroGen, Inc(FGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供FibroGen, Inc(FGEN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}